Shape Therapeutics
PrivateLast Round
Series B
Jul 15, 2021
Total Funding Raised
$147.5M
Company Overview
Shape Therapeutics is a biotechnology company that develops programmable RNA medicines to address genetic diseases using AI-driven RNA editing and gene therapy platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shape Therapeutics Comparables
Compare Shape Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRNA | 87% | |
| Ascidian Therapeutics | 84% | |
| Amber | 82% | |
Shape Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 15, 2021 | ||||
| Series A | Nov 5, 2019 |
Key People
Founding team and executive leadership
Shape Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CureDuchenne Ventures | Series A |
| New Enterprise Associates (NEA) | Series B, Series A |
| BioInnovation Capital | Series B |
| Mission BioCapital | Series B |
| Willett Advisors | Series B |
| Decheng Capital | Series B |
| Breton Capital Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
Collaborating with VectorY Therapeutics on vectorized antibody therapies for neurodegenerative diseases.
- Jul 15, 2021
$112M round led by Breton Capital Ventures and Decheng Capital.
Shape Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shape Therapeutics's valuation, stock price, and market status.